UK Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13

BMJ - 4 Oct, 2017
  • Tilis
  • by Tilis January 4, 2019

You May Also Like

In the realm of paper tigers – exploring the failings of AI ethics guidelines

https://algorithmwatch.org/en/ai-ethics-guidelines-inventory-upgrade-2020/

Tilis
Tilis

Q&A: How the EU’s Flawed Artificial Intelligence Regulation Endangers the Social Safety Net

https://www.hrw.org/sites/default/files/media_2021/11/202111hrw_eu_ai_regulation_qa_0.pdf

Tilis
Tilis

DIGITAL INDUSTRIAL POLICY FOR EUROPE

https://cerre.eu/wp-content/uploads/2022/12/Digital-Industrial-Policy-for-Europe.pdf

Tilis
Tilis